Novo Nordisk A/S: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

curprev 05:2905:29, 12 August 2023‎ 185.44.76.187 talk‎ 48,091 bytes +8,341‎ No edit summary undo Tag: Visual edit
curprev 00:4100:41, 12 August 2023‎ SaadYawar talk contribs‎ 39,750 bytes +6,339‎ Appendix - 3 financial statements undo Tag: Visual edit
curprev 00:2200:22, 12 August 2023‎ SaadYawar talk contribs‎ m 33,411 bytes +50‎ No edit summary undo Tag: Visual edit
curprev 00:2100:21, 12 August 2023‎ SaadYawar talk contribs‎ 33,361 bytes +80‎ Summary video undo Tag: Visual edit

curprev 14:5914:59, 11 August 2023‎ 185.44.76.187 talk‎ 33,281 bytes +15‎ No edit summary undo Tag: Visual edit

curprev 12:0612:06, 4 August 2023‎ SaadYawar talk contribs‎ 4,108 bytes +3,260‎ Summary, full page undo Tag: Visual edit

curprev 11:4011:40, 20 August 2022‎ 95.149.241.133 talk‎ 848 bytes +11‎ No edit summary undo Tag: Visual edit: Switched

curprev 16:4216:42, 13 August 2022‎ 109.180.50.163 talk‎ 837 bytes +15‎ No edit summary undo Tag: Visual edit: Switched

curprev 16:4116:41, 30 July 2022‎ Chris talk contribs‎ 822 bytes +822‎ Created page with "Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, gro..." Tag: Visual edit

Novo Nordisk A/S: Revision history

12 August 2023

11 August 2023

10 August 2023

9 August 2023

4 August 2023

20 August 2022

13 August 2022

30 July 2022